My aim is to use advanced Neuroimaging to further our understanding of the pathophysiology of brain disorders, in particular Epilepsy, but also Sleep disorders, Schizophrenia, the Dementias. In the case of my main research interest (Epilepsy) it is to red
Improving Human FMRI Through Modeling And Imaging Microvascular Dynamics
Funder
National Health and Medical Research Council
Funding Amount
$486,144.00
Summary
In this project we aim to establish a reliable vascular baseline to improve mapping of both small-scale functional architecture and large-scale brain networks in functional human brain mapping using MRI. By mapping the grey matter vasculature with high detail in both humans and animals, and by computing and matching of these atlases across species we will be able to validate this approach in vivo to confirm the better spatial specificity of the newly developed approach.
Structural And Functional Networks In The Human Brain: Disturbance In Disease And Influence Of Genes.
Funder
National Health and Medical Research Council
Funding Amount
$568,892.00
Summary
Professor Graeme Jackson is a Neurologist at the Austin Hospital whose research is dedicated to the problem of understanding how epilepsy occurs and devising strategies for successful treatment. He is Deputy Director and head of the epilepsy division of the Florey Neuroscience Institutes which has research dedicated advanced MR imaging systems and physics support largely dedicated to solving these problems in epilepsy. He has 170 plus papers, 10 cited over 200 times. Career citations exceed 6000 ....Professor Graeme Jackson is a Neurologist at the Austin Hospital whose research is dedicated to the problem of understanding how epilepsy occurs and devising strategies for successful treatment. He is Deputy Director and head of the epilepsy division of the Florey Neuroscience Institutes which has research dedicated advanced MR imaging systems and physics support largely dedicated to solving these problems in epilepsy. He has 170 plus papers, 10 cited over 200 times. Career citations exceed 6000.Read moreRead less
Brain surgery for the treatment of epilepsy is associated with a risk of cognitive impairment. Avoidance of disabling post-operative impairments depends in large measure on our ability to predict and measure individual patterns of language lateralization prior to neurosurgical intervention. Typical patterns of lateralisation cannot be assumed in patients with epileptogenic lesions. There appears to be a consensus that atypical representation is more frequent in patients with epilepsy than it is ....Brain surgery for the treatment of epilepsy is associated with a risk of cognitive impairment. Avoidance of disabling post-operative impairments depends in large measure on our ability to predict and measure individual patterns of language lateralization prior to neurosurgical intervention. Typical patterns of lateralisation cannot be assumed in patients with epileptogenic lesions. There appears to be a consensus that atypical representation is more frequent in patients with epilepsy than it is in the normal population, and values above 20% are not unrepresentative Partial epilepsy arises from a region in the brain and spreads to involve other areas. This is contrasted with generalised epilepsy, which appears to arise all over the brain simultaneously. Partial epilepsy is often associated with lesions such as tumors or hippocampal sclerosis, and often seizures are intractable. Patients with partial epilepsy have a number of sources of brain damage in the language areas. Primary brain changes may be pre-existing, which means they pre-date the onset of habitual seizures. They may consist of a focal developmental abnormality (a malformation of cortical development) or may represent a general genetic predisposition to seizures. Therefore, partial epilepsy is not only associated with severe abnormalities in epileptogenic region but also with additional widespread abnormalities in both hemispheres. There is also evidence for a correlation of abnormalities with seizure frequency with some suggestion that the duration of epilepsy may also increase the degree of abnormality in the hemisphere. The neuronal conditions in language cortex that give rise to altered lateralisation in function are currently not known. The primary aim of this study is to understand reorganisation of the language system in epilepsy by using the current most sensitive non-invasive methods of assessing brain damage and brain function, using magnetic resonance imaging.Read moreRead less
Evaluation Of Renal Masses Using Magnetic Resonance
Funder
National Health and Medical Research Council
Funding Amount
$657,897.00
Summary
This project will investigate use of an imaging instrument to identify renal cancers that are potentially harmless from aggressive renal cancers. Currently, such differentiation requires biopsies, and the outcome is often unnecessary surgical removal of whole or part of the diseased kidney. Long term, this project will provide knowledge to determine aggressiveness of a renal cancer non-invasively, without having to perform an operation. The approach was previously successful for breast cancer.
Magnetic Resonance Imaging Of Structural And Functional Connectivity In Lesion-negative Temporal Lobe Epilepsy Compared To Hippocampal Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$99,883.00
Summary
Epileptic seizures in the temporal lobe of the brain can affect how the temporal lobe connects to other brain regions. We are using new MRI techniques to investigate these altered connections, in patients who have no other abnormality on their brain scans. Our aim is to find distinctive patterns of altered connectivity, which will help us better understand this type of epilepsy.
Improving The Assessment Of Brain Tumour Treatment Outcome Using 18F-FDOPA PET-MRI Fusion
Funder
National Health and Medical Research Council
Funding Amount
$660,666.00
Summary
The mortality rate within the first year of diagnosis for high-grade brain tumours is approximately 80%. A major factor contributing to poor outcome measures is the limitation of current neuroimaging techniques. In a novel approach we propose to combine the information available from MRI and PET images to better define the extent of the tumour and provide markers of early treatment response. This improved diagnostic information should improve survival rates.
Novel Approaches To Improve Cognitive Recovery Following Stroke And Traumatic Brain Injury
Funder
National Health and Medical Research Council
Funding Amount
$344,724.00
Summary
Stroke and traumatic brain injury costs the Australian economy over $13 billion, annually. Both disorders result in impaired cognition that impedes individuals’ return to the community. Current rehabilitation strategies, however, fail to adequately rehabilitate cognitive deficits following these disorders. My fellowship will develop new strategies to improve rehabilitation of cognitive functions by using cutting-edge neuroimaging and electrophysiological techniques.
A Device For Simultaneous Continuous Acquisition Of EEG And MRI
Funder
National Health and Medical Research Council
Funding Amount
$179,401.00
Summary
We aim to further develop a world-leading method we invented that facilitates the simultaneous, continuous acquisition of the electroencephalogram (EEG - electrical brain waves measured at the scalp) and functional Magnetic Resonance Imaging (fMRI - images the location of brain activity throughout the brain). Combining the two permits non-invasive imaging of human brain function with the exquisite temporal resolution of EEG and the high spatial resolution and brain coverage afforded by fMRI.
Neural Signatures Of Disease Spread And Evolution In Motor Neurodegenerative Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
A lack of understanding of the earliest changes brought on by motor neurone disease (MND), otherwise known as amyotrophic lateral sclerosis (ALS), prevents early diagnosis and therapeutic intervention. The proposed project aims to comprehensively characterise neurological changes prior to disease onset in pre-symptomatic carriers with a known genetic mutation linked to MND using targeted neuropsychological assessments and advanced multi-modal neuroimaging to track disease progression.